Biotech buybacks: good or bad?

Article Abstract:

Experts provide their opinion on buyback undertaken by biotech companies, the reason for which they undertake them and to determine whether they are good or bad. In a buyback, the company takes cash from the company checking account and buys its own shares, which reduces the amount of shares outstanding, so that each shareholder owns a larger percentage of the business.

United States, Securities issued, listed, Capital Management-Stock Repurchase, Evaluation, Securities, Company securities, Stock redemption

---

Biotech IPOs-flop or pop?

Article Abstract:

Biotech companies measure stock market sentiment to find the best time to first offer their shares to the public in an initial public offering (IPO). An attempt is made to investigate whether the biotech companies have reached their desired levels as per their target.

Legal issues & crime, Analysis, Company legal issue, Investigations, Capital stock, Going public (Securities), Initial public offerings, Company public offering, Common stocks

---

Beware the biotech barker

Article Abstract:

Biotech companies are improving the barker skills so as to convince the investors to invest in their company. The barker skills of the early-stage biotech companies have confused the investors about the true status of the company.

Bark, Bark (Botany), Human genome

Similar abstracts:

• Abstracts: Biotech holds steady in Q4. Any diamonds in the diagnostic coal? Celltech acquisition sends mixed messages
• Abstracts: Proactive accounting: a key factor in the success of biotechnology startups. Strategic HR for today's biotechnology companies
• Abstracts: Biotrin assay to monitor cervical cancer exposure rates. Production technologies change flu vaccine landscape
• Abstracts: The minimum information required for reporting a molecular interaction experiment (MIMIx). In silico simulation of biological network dynamics
• Abstracts: Ligand selectivity and competition between enzymes in silico. Improving catalytic function by ProSAR-driven enzyme evolution

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.